However, they are also possible therapeutic agents due to their potentially beneficial physiological effects. The angiotensin receptor–neprilysin inhibitor, sacubitril/valsartan, simultaneously ...

Honda launched the SP 160 in India a few days ago, priced at Rs 91,771 onwards, ex-showroom. The new Honda SP 160 is available in two variants – Drum and Disc – the latter priced at Rs 1 lakh ...

Honda has launched an updated iteration of the SP 160 in India at a starting price of Rs. 1,21,951. The sporty commuter motorcycle is offered in two variants: single disc and dual disc ...

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

Diabetes is the leading cause of kidney failure, and there are estimated to be almost 850 million people worldwide with chronic kidney disease (CKD), including 160 million with type 2 diabetes.

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...